Announcements
1 October 2025
2024 MDPI Top 1000 Reviewers
2 October 2025
MDPI INSIGHTS: The CEO's Letter #27 - OASPA 2025, COUNTER 5.1, UK Summit in London, MDPI at the Italian Senate
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI at OASPA 2025: Embracing the Complexity of Open Access
From 22 to 24 September, I joined the OASPA 2025 Annual Conference in Leuven, Belgium, where the theme, “Embracing the Complexity – How do we get to 100% Open Access?” tackled the hard questions about the future of scholarly communication.
With MDPI a longstanding member of the Open Access Scholarly Publishing Association (OASPA) and Platinum sponsor of the conference, I was invited to present and participate in important discussions on how we can continue to move the needle in Open Access (OA) publishing.
From 50% to 100% Open Access
Last year’s OASPA conference celebrated a major milestone – reaching 50% of global research outputs published as OA. But, as noted during the conference, this was the “easy” part. The challenge ahead is much tougher: how do we take OA from 50% to 100%? For many academics and institutions, OA is still relatively new, and thus it is essential for us to continue educating people as to what OA is, how it works, and why it matters.
Stefan Tochev (CEO, MDPI) presenting at OASPA’s 2025 Annual Conference in Leuven, Belgium.
MDPI’s perspective
At MDPI, we are fully committed to this. As a 100% OA publisher, our growth is inseparable from the success of OA itself. In many ways, MDPI is a byproduct of the global adoption of OA, and we play an important role in helping to advance it further.
I had the opportunity to share MDPI’s perspective in the panel discussion entitled: "Hello from the other side: views from fully Open Access journals using APCs," alongside industry colleagues from PLOS, eLife, AOSIS, and Frontiers.
Instead of giving a standard presentation, I highlighted aspects of MDPI that the audience might not be aware of. I also presented on the opportunities and challenges facing publishers that are already fully OA, the importance of diverse models in achieving 100% OA, and why OA is the baseline while Open Science is the future.
Recognizing Gold OA
As part of the panel, I had undertaken to make some bold and provocative statements. I therefore emphasized a point that is sometimes overlooked: we didn’t reach 50% OA without Gold OA – it accounts for more than half of all OA publications today. And we certainly won’t reach 100% OA without it.
“By educating the community and working together, we can continue to take Open Science to the next level”
“When people speak about Gold OA and MDPI, they should ‘put some respek on our name.”
MDPI is a leader in Gold OA and has been a driver of this progress at scale.
While Gold OA and MDPI are sometimes slighted, both deserve recognition for their contributions to advancing Open Science globally.
I closed my presentation with a reminder that the good we do is sometimes overlooked, and that when people speak about Gold OA and MDPI, they should "put some respek on our name."
I’m pleased to have seen attendees sharing positive experiences with MDPI, reminding us that we bring real value to the OA movement and deserve a stronger reputation. We also engaged in constructive conversations about various topics, including cost transparency.
A few themes that I took away from the conference:
- Quality and integrity matter as much as access. OA publishers must not lose sight of research integrity, inclusivity, and sustainability while pursuing 100% OA.
- Global collaboration is essential. Policies, funding models, and infrastructure differ around the world, and we will need cross-border collaboration to make OA a truly global reality.
- Open Science is the bigger story. OA is just the first step – the future lies in open data, open peer review, research reproducibility, etc.
“MDPI’s scale allows us to better support authors, reinvest in communities, and push Open Science forward”
How we communicate MDPI’s role
For us at MDPI, this is also a reminder of how we communicate externally. When we tell our story, we shouldn’t forget to start with the bigger picture – Open Science and Open Access. Then we connect it to MDPI, our journals, services, and initiatives, exemplifying the fact that we are part of a mission larger than ourselves.
MDPI colleagues Clàudia Aunós (Society Partnerships), Marta Colomer (External Affairs), Stefan Tochev (CEO), and Nikola Paunovic (Scilit), at OASPA’s 2025 Annual Conference in Leuven, Belgium.
The journey to 100% OA will not be simple. But by educating the community and working together, we can continue to take Open Science to the next level.
Impactful Research
MDPI becomes COUNTER 5.1 compliant across 480+ Journals
I’m pleased to share that MDPI has officially become COUNTER 5.1 compliant and has joined the COUNTER Registry.
For those who might not be familiar with it, COUNTER provides international standards for tracking and reporting how research is being used. By becoming COUNTER 5.1 compliant, MDPI can now deliver credible, comparable, and transparent usage reports across our entire journal portfolio.
“MDPI is showing that they want to be measured against the same yardstick as other publishers”
Why is this important?
Because usage statistics aren’t just numbers: they’re powerful tools that help our authors, institutions, and consortia understand the real impact of their research. With COUNTER compliant reports, our institutional partners can now make more informed decisions about publishing agreements, funding allocations, and the long-term value of Open Access.
In practical terms, MDPI will now provide Platform, Title, and Item Reports, with standardized usage views available at the institute and consortium level. These reports cover usage from January 2024 onwards and will be updated monthly. Institutions will be able to access them via SuSy, or automatically through the COUNTER API.
I’d like to highlight and thank Becky Castellon, our Institutional Partnerships Manager, who has played a key role in driving this project forward. Becky captured it perfectly when she said: "Through these usage reports, our global research community can access trustworthy data about how their work is being used and accessed
This information is often vital for reviewing publishing partnership agreements and for making informed decisions about future funding allocations."
We also received encouraging feedback from Tasha Mellins-Cohen, Executive Director at COUNTER Metrics:
"We’re delighted to see born-OA publishers engaging with COUNTER. Our normalised usage metrics are relied on as the basis for credible return-on-investment calculations by libraries worldwide. By adopting the COUNTER standard, MDPI is showing that they want to be measured against the same yardstick as other publishers."
For MDPI, this milestone is another step in our commitment to transparency, trust, and impact. By adopting COUNTER’s standards, we’re not just aligning with best practice; we’re ensuring that Open Access publishing is measured on the same terms as traditional publishing, proving its value in concrete and globally recognized ways.
This is an important milestone for MDPI, but more importantly for the researchers, librarians, and institutions we serve. Transparency builds trust, and COUNTER compliance helps us show the global reach and influence of Open Access publishing in the clearest way possible.
Inside Research
Lin Li (Publisher, MDPI), Stefan Tochev (CEO, MDPI, Prof. Chengkuo Lee (Editor-in-Chief, AI Sensors), and Constanze Schelhorn (Head of Indexing) at restaurant in Basel, Switzerland.
Welcoming Prof. Lee (EiC of AI Sensors) to Basel
On 11 September, we welcomed Prof. Dr. Chengkuo Lee, Editor-in-Chief of our new journal AI Sensors, to our Basel office. Prof. Lee is a high profiled researcher (h-index 104, 37,000+ citations), a longtime collaborator with MDPI (25 published articles), and has already chaired several AI Sensors (AIS)-related conferences with us, including the recent event in Kuala Lumpur, where AI Sensors held its first editorial board meeting.
Stefan Tochev (CEO, MDPI) showing Special Issue reprint books as part of a tour of MDPI’s Basel office.
Every journal has a story
During his visit, we exchanged ideas on how to build the journal’s identity and impact. A key takeaway that I shared was that every journal has a story: its vision, its purpose, and the community it brings together.
That story is what connects with readers and authors, beyond metrics alone.
I encouraged everyone working on journals to reflect: What is the story of your journal? And how can you bring that story to the forefront in how you communicate about it?
How MDPI supports new journals
Constanze Schelhorn (Head of Indexing, MDPI) presenting on the MDPI indexing process at the company’s headquarters in Basel.
We also shared with Prof. Lee how MDPI supports journals through our Institutional Open Access Program, indexing expertise, and the work of our Journal Relationship Specialists.
Launching a new journal is ambitious, but with our strong track record (93% Scopus and 87% Web of Science acceptance rates in 2024), Prof. Lee felt confident that AI Sensors will find its place in the scholarly landscape.
Having spent some hours together, it’s clear that Prof. Lee is not only an Editor-in-Chief but also an ambassador for MDPI. His leadership and collaboration reflect the mission MDPI by which MDPI lives: accelerating Open Access and advancing Open Science.
Special thanks to Constanze Schelhorn (Head of Indexing), Ting Leng (JRS, Managing Editor, AI Sensors), Lin Li (Publisher, AI Sensors), Aimar Xiong (Publisher), and Christian Eberhard (Office Administrator, Basel), for organizing and hosting the meeting.
Coming Together for Science
Highlights from the MDPI UK Summit in London
I was pleased to be back in the UK in September, supporting our Manchester team in hosting their first MDPI Summit in London. This day-and-a-half private event brought together 25 Chief Editors and Associate Editors to exchange knowledge, learn about latest developments at MDPI, and engage in discussions on advancing Open Science. The program included MDPI and guest presentations, and Q&A sessions.
Why these summits matter
Our Summits provide a platform to:
- Share updates on the latest developments at MDPI, our editorial processes, research integrity practices, and indexing.
- Highlight collaborations with institutions and societies in the region.
- Offer external perspectives from guest speakers.
- Create space for Chief Editors to share their insights, ask questions, network, and help shape MDPI’s path forward.
These gatherings are more than updates: they improve our relationships with Chief Editors, who serve not only as leaders of their journals but also as ambassadors for MDPI within the research community. We often hear that this type of event is unique, something many other publishers do not provide. It shows that we care and are willing to go the extra mile to recognize and engage our key collaborators.
|
|
|
|
MDPI and the UK: Key facts
- With over 80,000 publications, the UK is MDPI’s eighth-largest contributor.
- MDPI is the fourth-largest publisher in the UK, accounting for 11% of the country’s 89,526 Open Access publications in 2024.
- We collaborate with more than 4,000 active UK Editorial Board Members, 48% of whom have an H-index above 26. This includes 49 Editors-in-Chief and 74 Section Editors-in-Chief.
- MDPI maintains over 1,000 IOAP agreements worldwide, with 63 from the UK.
“We are willing to go the extra mile to recognize and engage our key collaborators”
|
|
|
|
|
|
|
|
Agenda highlights:
- MDPI Overview, Open Access, and UK Collaboration – Stefan Tochev (CEO, MDPI)
- MDPI Editorial Process – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
- Research Integrity and Publication Ethics – Daisy Fenton (Research Integrity Specialist, MDPI)
- Institutional Partnerships – Becky Castellon (Institutional Partnerships Manager, MDPI)
- Promoting and Developing Your Journal – Prof. Fabio Tosti (Editor-in-Chief of NDT)
- Indexing to Impact – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
- Engaging our Academic Community – Jaime Anderson Anderson (UK Operations Manager, MDPI)
- Closing Remarks – Stefan Tochev (CEO, MDPI)
MDPI colleagues Stefan Tochev (CEO), Jaime Anderson Anderson (UK Operations Manager), Dr. Michael O’Sullivan (Scientific Quality Advisor Lead), Becky Castellon (Institutional Partnerships Manager), Daisy Fenton (Research Integrity Specialist) at the MDPI UK 2025 Summit in London.
Thank you!
A special thank-you to the Manchester team and all colleagues behind the scenes who made this Summit a success. Your efforts are greatly appreciated. We look forward to building on this momentum with future Summits in Europe and beyond.
Closing Thoughts
Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI) and Stefan Tochev (CEO, MDPI) participating in a press conference at the Italiane Senate in Rome to promote the 2nd International Conference on Environmental Medicine (ICEM)
MDPI at the Italian Senate: Promoting Environmental Medicine and Open Science
On 16 September, Dr. Giulia Stefenelli (Scientific Communications Lead) and I had the honour of participating in a press conference at the Italian Senate in Rome, organized by the Italian Society of Environmental Medicine (SIMA) to promote the upcoming 2nd International Conference on Environmental Medicine (ICEM) (20–21 November 2025).
This is an important event for MDPI, as we are the exclusive publishing partner for ICEM and have recently launched a new journal with SIMA, further building our presence both in Italy and within this important field of research.
Why this matters
- The promotion of ICEM has received extensive national media coverage (more than 15 mentions in major Italian outlets; see links below).
- The press conference brought together leading policymakers, academics, and Nobel Laureates to emphasize the impact of environmental exposures and epigenetics on human health.
- We were introduced to government ministries, university rectors, and influential stakeholders, which helps us bolster MDPI’s visibility and reputation in Italy.
Highlights
Nobel Laureate Sir Richard Roberts joined the discussion, underlining the importance of environmental medicine in shaping future health outcomes. Nobel Laureate Prof. Dr. Tong Zhu (Peking University) will also speak at the November conference.
Institutional representatives included the Italian Minister of the Environment and Energy Security, the Italian Undersecretary for Health, and senior officials from the World Health Organization.
In my closing remarks, I highlighted that:
“Over the past five years, about 65% of research published in Italy has been Open Access, compared to an average of 55% worldwide.”
Italian research ranked seventh among the top 20 countries in average citations during this period, reflecting its strong international influence. Not only is Italy producing a high volume of research; it is also producing research of outstanding quality.
MDPI’s role
This event was not only about promoting ICEM but also about showcasing MDPI’s commitment to Open Access and our ability to connect scientific publishing with leading academic, medical, and policy institutions.
As Giulia Stefenelli noted:
“This event was highly relevant for MDPI, as it not only showcased our strong commitment to OA but also emphasized our role in advancing important fields such as Environmental Medicine.”
Learn more
- Watch the full press conference (Radio Radicale)
- Giulia’s speech: 33:20 (in Italian)
- Stefan’s speech: 57:50 (in English)
- ICEM 2025 Conference Program
- Selected media coverage:
This moment at the Italian Senate shows how MDPI can connect publishing with science, policy, and society to help advance both Open Science and environmental health research on a global stage.
|
|
|
In Rome with Sir Richard Roberts (photo left) and Prof. Giuseppe Novelli (EiC of MDPI journal COVID).
Chief Executive Officer
MDPI AG
30 September 2025
Nobel Prize — The Science Behind the Prize
Nobel Prizes are the world’s most prestigious recognition of scientific breakthroughs, honoring discoveries that push the boundaries of knowledge and reshape entire fields. They bring into the public eye researchers whose work might otherwise remain known only within specialized circles.
For many, winning a Nobel Prize is a surreal experience. Laureates often describe a mix of joy, humility, reflection, and gratitude for the teams and collaborators whose contributions made the achievement possible. Behind every Nobel-winning idea lies years of careful, incremental work—a process that often goes unseen.
When Prof. Steven Weinberg won the Nobel Prize in Physics in October 1979, his wife Louise, a legal scholar, reminded him to keep doing the ordinary hard work of science, joking: “Now you have to write some unimportant papers.” True to form, Weinberg continued to push the boundaries of our understanding of the Universe, showing that curiosity and dedication extend far beyond the moment of recognition (Hofmann 2025: https://www.mdpi.com/2073-8994/17/6/840).
Discover the science behind the world’s most transformative ideas
Over the years, dozens of Nobel laureates have published their work with MDPI, entrusting our open access journals to disseminate their findings to a global audience. As of 2024, more than 40 laureates have contributed over 115 articles across 35 journals, ranging from pioneering research on microRNAs and mRNA therapeutics, to fundamental insights in theoretical physics, and advances in structural biology.
We regularly spotlight how Nobel Prize–winning research intersects with the contributions of our authors. This not only celebrates the achievements of the laureates, but also underscores the role of open access in ensuring that transformative science reaches the widest possible audience.
On this page, we invite you to explore selected works by Nobel laureates within the MDPI portfolio, and to join us in celebrating the global impact of their ideas.
The Nobel Prize in Physiology or Medicine 2025 will be announced on October 6 at 11:30 am CEST (at the earliest), awarded by the Nobel Assembly at Karolinska Institutet, Stockholm, Sweden. MDPI sincerely invites you to explore research in a related field.
The Science Behind the Prize: 2025 Nobel Physiology or Medicine Roundtable
6 October 2025, 03:30 pm (CEST)
Free to register for this webinar here!
The Nobel Prize in Physics 2025 will be announced on October 7 at 11:45 am CEST (at the earliest), awarded by the Royal Swedish Academy of Sciences, Stockholm, Sweden. MDPI sincerely invites you to explore research in a related field.
The Science Behind the Prize: 2025 Nobel Physics Roundtable
7 October 2025, 02:30 pm (CEST)
Free to register for this webinar here!
The Nobel Prize in Chemistry 2025 will be announced on October 8 at 11:45 am CEST (at the earliest), awarded by the Royal Swedish Academy of Sciences, Stockholm, Sweden. MDPI sincerely invites you to explore research in a related field.
28 September 2025
Journal of Personalized Medicine | Highly Cited Papers and Hot Topic Special Issues on Respiratory Diseases
We are delighted to share some of the highly cited papers on respiratory diseases that were published in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426). We would also like to promote some Special Issues on this topic that are currently open for submission and may be of interest to you.
- “Lung and Gut Microbiome in COPD”
by Efstathios Karakasidis, Ourania S. Kotsiou and Konstantinos I. Gourgoulianis
J. Pers. Med. 2023, 13(5), 804; https://doi.org/10.3390/jpm13050804
Available online: https://www.mdpi.com/2075-4426/13/5/804
Cited by 19 | Viewed by 4230 - “Patient Self-Inflicted Lung Injury—A Narrative Review of Pathophysiology, Early Recognition, and Management Options”
by Peter Sklienka, Michal Frelich and Filip Burša
J. Pers. Med. 2023, 13(4), 593; https://doi.org/10.3390/jpm13040593
Available online: https://www.mdpi.com/2075-4426/13/4/593
Cited by 18 | Viewed by 10750 - “Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab”
by Giovanna Lucia Piazzetta, Nadia Lobello, Emanuela Chiarella, Alberta Rizzuti, Corrado Pelaia, Girolamo Pelaia and Nicola Lombardo
J. Pers. Med. 2023, 13(9), 1404; https://doi.org/10.3390/jpm13091404
Available online: https://www.mdpi.com/2075-4426/13/9/1404
Cited by 16 | Viewed by 3450 - “The Role of Small Airway Disease in Pulmonary Fibrotic Diseases”
by Georgios I. Barkas, Zoe Daniil and Ourania S. Kotsiou
J. Pers. Med. 2023, 13(11), 1600; https://doi.org/10.3390/jpm13111600
Available online: https://www.mdpi.com/2075-4426/13/11/1600
Cited by 12 | Viewed by 5640 - “Prediction of Asthma Exacerbations in Children”
by Evangelia Sarikloglou, Sotirios Fouzas and Emmanouil Paraskakis
J. Pers. Med. 2024, 14(1), 20; https://doi.org/10.3390/jpm14010020
Available online: https://www.mdpi.com/2075-4426/14/1/20
Cited by 9 | Viewed by 3530 - “Insights into Personalised Medicine in Bronchiectasis”
by Clementine S. Fraser and Ricardo J. José
J. Pers. Med. 2023, 13(1), 133; https://doi.org/10.3390/jpm13010133
Available online: https://www.mdpi.com/2075-4426/13/1/133
Cited by 8 | Viewed by 6735 - “Sarcopenia and Tuberculosis: Is There Any Connection?”
by Nikolaos D. Karakousis, Konstantinos I. Gourgoulianis and Ourania S. Kotsiou
J. Pers. Med. 2023, 13(7), 1102; https://doi.org/10.3390/jpm13071102
Available online: https://www.mdpi.com/2075-4426/13/7/1102
Cited by 7 | Viewed by 2735 - “Speaking of the “Devil”: Diagnostic Errors in Interstitial Lung Diseases”
by Raluca Ioana Arcana, Radu Adrian Crișan-Dabija, Bogdan Caba, Alexandra-Simona Zamfir, Tudor Andrei Cernomaz, Andreea Zabara-Antal, Mihai Lucian Zabara, Ștefăniță Arcana, Dragoș Traian Marcu and Antigona Trofor
J. Pers. Med. 2023, 13(11), 1589; https://doi.org/10.3390/jpm13111589
Available online: https://www.mdpi.com/2075-4426/13/11/1589
Cited by 7 | Viewed by 1845
Special Issues:
|
“Innovations in Airway Diseases” Guest Editor: Dr. Ourania S. Kotsiou Submission deadline: 31 October 2025 |
“Novel Challenges and Advances in Respiratory Diseases” Guest Editor: Dr. Vasiliki E. Georgakopoulou Submission deadline: 30 June 2026 |
|
|
|
You can view the abovementioned articles and submit relevant papers to JPM via https://www.mdpi.com/journal/jpm.
JPM Editorial Office
28 September 2025
Journal of Personalized Medicine | Editor’s Choice Articles in Q3 of 2025
28 September 2025
Meet Us at Kidney Week 2025, 6–9 November 2025, Houston, USA
19 September 2025
MDPI Webinar | The Science Behind the Prize: 2025 Nobel Physiology or Medicine Roundtable, 6 October 2025
Coinciding with the announcement of the 2025 Nobel Prize in physiology or medicine, this forum underscores the importance of recognizing outstanding achievements that push the boundaries of human knowledge and understanding. It represents a valuable opportunity to exchange ideas on the advancements driving scientific progress and to inspire the next generation of gifted scientists.
General topics of discussion for this event will include the following:
- Breakthrough research shaping the future of physiology or medicine;
- Reflecting on past Nobel Prize-winning work and its legacy;
- The key trends driving innovation in physiology or medicine today;
- Exploring the societal and scientific contributions of physiology or medicine research.
Date: 6 October 2025
Time: 3:30 p.m. CEST | 9:30 a.m. EDT | 9:30 p.m. CST (Asia)
Webinar ID: 852 3554 5031
Register now for free!
After registering, you will receive a confirmation email with information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Please register anyway; the session will be recorded, and we will let you know when the recording is available for viewing.
Program:
|
Speaker |
Agenda |
Time in CEST |
Time in EDT |
Time in CST Asia |
|
MDPI Host |
Opening Remarks |
3:30–3:35 p.m. |
9:30–9:35 a.m. |
9:30–9:35 p.m. |
|
Speakers: |
Expert Commentary: Breakthroughs and Future Impacts of Physiology or Medicine Research |
3:35–4:15 p.m. |
9:35–10:15 a.m. |
9:35–10:15 p.m. |
|
|
Break |
4:15–4:20 p.m. |
10:15–10:20 a.m. |
10:15–10:20 p.m. |
|
MDPI Host |
Stating the Prize Winner |
4:20–4:25 p.m. |
10:20–10:25 a.m. |
10:20–10:25 p.m. |
|
Speakers: |
Reflective Discussion: What the Nobel Prize Means for Science and Society |
4:25–4:45 p.m. |
10:25–10:45 a.m. |
10:25–10:45 p.m. |
|
MDPI Host |
Closing Remarks |
4:45–4:50 p.m. |
10:45–10:50 a.m. |
10:45–10:50 p.m. |
Webinar Keynote Speakers:
- Prof. Dr. Jacek Z. Kubiak, CNRS/University Rennes UMR 6290, Institute of Genetics and Development of Rennes (IGDR), Rennes, France;
- Prof. Dr Carlos S. Moreno, Department of Pathology & Laboratory Medicine, Department of Biomedical Informatics, Department of Urology, Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, GA, USA;
- Prof. Dr Claus Jacob, Division of Bioorganic Chemistry, School of Pharmacy, University of Saarland, Saarland, Germany.
For more information about this webinar, please visit the following link: https://sciforum.net/event/NPR2025PM.
If you have any questions about this webinar, please contact webinar@mdpi.com.
MDPI Webinar Secretariat
15 September 2025
International Day for Interventional Cardiology, 16 September 2025
The International Day for Interventional Cardiology is observed annually on 16 September. This day is dedicated to raising awareness about the field of interventional cardiology and its role in treating heart diseases through minimally invasive procedures. It highlights advancements and achievements in the field, emphasizing the importance of cardiovascular health and innovative medical interventions.
In recognition of this important day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine. We believe that promoting such research contributes to enhanced public awareness and a greater understanding of cardiovascular diseases and procedures, related complications, prevention and care.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
“Cellular and Molecular Bases for the Application of Polyphenols in the Prevention and Treatment of Cardiovascular Disease”
by Carlo Caiati and Emilio Jirillo
Diseases 2025, 13(7), 221; https://doi.org/10.3390/diseases13070221
“Comparative Analysis of Cardiovascular Outcomes in Type 2 Diabetes Patients Engaging in Aerobic, Resistance, and Combined Training: A Systematic Review”
by Sayed Alireza Mousavi Zadeh, Giuseppe Caminiti, Maurizio Aracri, Massimo Pieri, Anna Paola Mitterhofer, Antonino De Lorenzo, Sergio Bernardini, Pasquale Farsetti, Maurizio Volterrani, Rosario Barone et al.
Diabetology 2025, 6(5), 38; https://doi.org/10.3390/diabetology6050038
“Medical Therapy Versus Percutaneous Coronary Intervention in Patients with Myocardial Bridging from a National Population-Based Cohort Study: The Use of Big Data Analytics”
by Chayakrit Krittanawong, Song Peng Ang, Fernando Alexis Padilla, Yusuf Kamran Qadeer, Zhen Wang, Nicola Gaibazzi, Samin K. Sharma, Carl J. Lavie, Hartzell V. Schaff and Ernst R. Schwarz
Cardiogenetics 2025, 15(2), 10; https://doi.org/10.3390/cardiogenetics15020010
“Computed Tomography Angiography Identified High-Risk Coronary Plaques: From Diagnosis to Prognosis and Future Management”
by Kyriakos Dimitriadis, Nikolaos Pyrpyris, Panagiotis Theofilis, Emmanouil Mantzouranis, Eirini Beneki, Panagiotis Kostakis, George Koutsopoulos, Konstantinos Aznaouridis, Konstantina Aggeli and Konstantinos Tsioufis
Diagnostics 2024, 14(15), 1671; https://doi.org/10.3390/diagnostics14151671
“Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures”
by Nikolaos Ktenopoulos, Odysseas Katsaros, Anastasios Apostolos, Maria Drakopoulou, Grigorios Tsigkas, Constantinos Tsioufis, Periklis Davlouros, Konstantinos Toutouzas and Antonios Karanasos
Life 2024, 14(7), 842; https://doi.org/10.3390/life14070842
“Zero-Fluoroscopy Catheter Ablation of Right Appendage Focal Atrial Tachycardia in a Pregnant Woman”
by Federica Troisi, Noemi Valenti, Federico Quadrini, Nicola Vitulano, Antonio Di Monaco, Imma Romanazzi, Rosa Caruso, Rocco Orfino and Massimo Grimaldi
Clin. Pract. 2024, 14(3), 946-953; https://doi.org/10.3390/clinpract14030075
“In-Stent Restenosis Overview: From Intravascular Imaging to Optimal Percutaneous Coronary Intervention Management”
by Neda Shafiabadi Hassani, Lucas Carlini Ogliari, Pedro Rafael Vieira de Oliveira Salerno, Gabriel Tensol Rodrigues Pereira, Marcelo Harada Ribeiro and Luis Augusto Palma Dallan
Medicina 2024, 60(4), 549; https://doi.org/10.3390/medicina60040549
“The Application of Precision Medicine in Structural Heart Diseases: A Step towards the Future”
by Grigorios Chrysostomidis, Anastasios Apostolos, Amalia Papanikolaou, Konstantinos Konstantinou, Grigorios Tsigkas, Antigoni Koliopoulou and Themistokles Chamogeorgakis
J. Pers. Med. 2024, 14(4), 375; https://doi.org/10.3390/jpm14040375
“Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations”
by Hien C. Nguyen, Jefferson C. Frisbee and Krishna K. Singh
Hearts 2024, 5(1), 54-74; https://doi.org/10.3390/hearts5010005
“Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease”
by Keith A. Webster
Genes 2024, 15(1), 135; https://doi.org/10.3390/genes15010135
“A Refractory Electrical Storm after Acute Myocardial Infarction: The Role of Temporary Ventricular Overdrive Pacing as a Bridge to ICD Implantation”
by Mijo Meter and Josip Andelo Borovac
Pathophysiology 2024, 31(1), 44-51; https://doi.org/10.3390/pathophysiology31010004
“Transcatheter Aortic Valve Replacement: Current Status and Future Indications”
by Manish Vinayak, Pier Pasquale Leone, Richard Tanner, Vishal Dhulipala, Anton Camaj, Rakhee Rajendra Kumar Makhija, Amit Hooda, Annapoorna S. Kini, Samin K. Sharma and Sahil Khera
J. Clin. Med. 2024, 13(2), 373; https://doi.org/10.3390/jcm13020373
“Gender Disparities after Transcatheter Aortic Valve Replacement with Newer Generation Transcatheter Heart Valves: A Systematic Review and Meta-Analysis”
by Angkawipa Trongtorsak, Sittinun Thangjui, Pabitra Adhikari, Biraj Shrestha, Jakrin Kewcharoen, Leenhapong Navaravong, Somsupha Kanjanauthai, Steve Attanasio and Hammad A. Saudye
Med. Sci. 2023, 11(2), 33; https://doi.org/10.3390/medsci11020033
|
“Advances in the Diagnosis and Management of Cardiovascular Diseases” |
“Pediatric Cardiology Frontiers: Innovations in Diagnosis and Treatment” |
|
“Clinical Advances in Cardiovascular Interventions” |
“New Horizons in the Diagnosis, Prevention and Treatment of Peripheral Artery Disease in Diabetes” |
|
“HTAAD: Unraveling the Molecular and Clinical Complexity of Heritable Thoracic Aortic Disease” |
“Insights into the Management of Cardiovascular Disease Risk Factors” |
|
“Recent Advances in Interventional Cardiology” |
“Interventional Cardiology: Advances in Personalized Treatment and Management” |
 |
 |
11 September 2025
Meet Us at the 38th Annual Congress of the European Association of Nuclear Medicine, 4–8 October 2025, Barcelona, Spain
7 September 2025
World Duchenne Awareness Day—“Family: The Heart of Care”, 7 September 2025
Duchenne muscular dystrophy is a condition that, while currently incurable, is the focus of extensive research aimed at prevention and treatment to improve the health and quality of life for those affected. Each year, we observe World Duchenne Awareness Day to enhance public understanding of the profound health, social, and economic impacts of Duchenne muscular dystrophy (DMD) and to bolster our efforts in combating this condition.
The day marks the birthday of Guillaume Duchenne, the physician who first described the disorder in the 19th century, thus setting the stage for advancements in diagnosis and care. It is our hope that esteemed journals in the fields of Biology, Life Sciences, and Medicine & Pharmacology at MDPI will continue to act as forums for the dissemination of cutting-edge research and innovative concepts related to the prevention and treatment of Duchenne muscular dystrophy.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
“CRISPR/Cas9-Targeted Myostatin Deletion Improves the Myogenic Differentiation Parameters for Muscle-Derived Stem Cells in Mice”
by Mohamed I. Elashry, Victoria C. Schneider, Manuela Heimann, Sabine Wenisch and Stefan Arnhold
J. Dev. Biol. 2025, 13(1), 5; https://doi.org/10.3390/jdb13010005
“Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study”
by Victor Augusto Ramos Fernandes, Gabriela Pereira dos Santos, Amilton Iatecola, Daniela Vieira Buchaim, Ionaly Judith Faria Garcia, Carlos Henrique Bertoni Reis, Lívia Maluf Menegazzo Bueno, Bruna Trazzi Pagani, Rogerio Leone Buchaim and Marcelo Rodrigues da Cunha
Pathophysiology 2025, 32(1), 2; https://doi.org/10.3390/pathophysiology32010002
“Appendicular Skeletal Muscle Index Is Positively Related to Mediterranean Diet Adherence in University Students”
by Paraskevi Detopoulou, Olga Magni, Ioanna Pylarinou, Despoina Levidi, Vassilios Dedes, Milia Tzoutzou, Konstantina Argyri, Evangelia Fappa, Aristea Gioxari and George Panoutsopoulos
Diseases 2025, 13(1), 3; https://doi.org/10.3390/diseases13010003
“MRI-Based Circumferential Strain in Boys with Early Duchenne Muscular Dystrophy Cardiomyopathy”
by Zhan-Qiu Liu, Nyasha G. Maforo, Patrick Magrath, Ashley Prosper, Pierangelo Renella, Nancy Halnon, Holden H. Wu and Daniel B. Ennis
Diagnostics 2024, 14(23), 2673; https://doi.org/10.3390/diagnostics14232673
“An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database”
by Jamie Leckie, Abdullah Zia and Toshifumi Yokota
Genes 2024, 15(11), 1489; https://doi.org/10.3390/genes15111489
“A Comprehensive Workplace Exercise Intervention to Reduce Musculoskeletal Pain and Improve Functional Capacity in Office Workers: A Randomized Controlled Study”
by Konstantina Karatrantou and Vassilis Gerodimos
Healthcare 2024, 12(9), 915; https://doi.org/10.3390/healthcare12090915
“Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI”
by Lara Schlaffke, Robert Rehmann, Anne-Katrin Güttsches, Matthias Vorgerd, Christine H. Meyer-Frießem, Hubert R. Dinse, Elena Enax-Krumova, Martijn Froeling and Johannes Forsting
J. Clin. Med. 2024, 13(7), 1958; https://doi.org/10.3390/jcm13071958
“Nuclear Small Dystrophin Isoforms during Muscle Differentiation”
by Tina Donandt, Vanessa Todorow, Stefan Hintze, Alexandra Graupner, Benedikt Schoser, Maggie C. Walter and Peter Meinke
Life 2023, 13(6), 1367; https://doi.org/10.3390/life13061367
“Orphan Drugs in Neurology—A Narrative Review”
by Carmen Adella Sirbu, Raluca Ivan, Francois Jerome Authier, Florentina Ionita-Radu, Dragos Catalin Jianu, Octavian Vasiliu, Ciprian Constantin and Sorin Tuță
J. Pers. Med. 2023, 13(3), 420; https://doi.org/10.3390/jpm13030420
| “Muscle Wasting, Aging, and Cancer: The Effects of Physical Exercise” Guest Editor: Prof. Dr. Paula Tavares Submission deadline: 28 November 2025 |
“Genetic Diagnosis and Treatment of Duchenne Muscular Dystrophy” Guest Editor: Dr. Liubov V. Gushchina Submission deadline: 20 December 2025 |
 |
 |
| “Muscular Dystrophy: From Molecular Basis to Therapies: 2nd Edition” Guest Editor: Dr. Francesca Sciandra and Dr. Kinga I. Gawlik Submission deadline: 15 January 2026 |
“Dysfunctions or Approaches of the Musculoskeletal System” Guest Editors: Prof. Dr. Paloma Moro and Prof. Dr. Jorge Rodriguez Submission deadline: 28 February 2026 |
 |
 |
| “Neuromuscular Diseases and Musculoskeletal Disorders” Guest Editor: Dr. Anna Christakou Submission deadline: 28 February 2026 |
“Mitochondrial Function and Dysfunction in Developmental Biology Metabolism” Guest Editor: Prof. Dr. Simon J. Conway Submission deadline: 15 March 2026 |
 |
 |
